Current Controversies in the Management of Malignant Pleural Effusions

Maree Azzopardi; José M. Porcel; Coenraad F. N. Koegelenberg; Y. C. Gary Lee; Edward T. H. Fysh

doi:10.1055/s-0034-1395795

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2014; 35(06): 723-731
DOI: 10.1055/s-0034-1395795

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Current Controversies in the Management of Malignant Pleural Effusions

Maree Azzopardi

¹Thoracic Medicine Program, The Prince Charles Hospital, Brisbane, Australia

,

José M. Porcel

²Pleural Diseases Unit, Department of Internal Medicine, Arnau de Vilanova University Hospital, Biomedical Re search Institute of Lleida, Lleida, Spain

,

Coenraad F. N. Koegelenberg

³Division of Pulmonology, Department of Medicine, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa

,

Y. C. Gary Lee

⁴Centre for Asthma, Allergy & Respiratory Research, School of Medicine & Pharmacology, University of Western Australia, Perth, Australia

⁵Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia

,

Edward T. H. Fysh

⁴Centre for Asthma, Allergy & Respiratory Research, School of Medicine & Pharmacology, University of Western Australia, Perth, Australia

⁵Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, Australia

› Author Affiliations

Abstract

Malignant pleural effusion (MPE) can complicate most malignancies and is a common clinical problem presenting to respiratory and cancer care physicians. Despite its frequent occurrence, current knowledge of MPE remains limited and controversy surrounds almost every aspect in its diagnosis and management. A lack of robust data has led to significant practice variations worldwide, inefficiencies in healthcare provision, and threats to patient safety. Recent studies have highlighted evolving concepts in MPE care that challenge traditional beliefs. Advancing laboratory techniques have improved the diagnostic yield from pleural fluid cytology, minimizing the need for invasive tissue biopsies, even in many cases of mesothelioma. Imaging-guided biopsy is comparable to thoracoscopy in suitable patients, if cytological examination was noncontributory. Cumulating evidence for the benefits of indwelling pleural catheters (IPCs) has led some centers to adopt this approach as first-line definitive management for MPE over conventional talc pleurodesis. The optimal technique of talc pleurodesis is still debated despite its use for many decades. Strategies combining pleurodesis and IPC are being studied. MPE consists of a heterogenous group of diseases and careful phenotyping of malignant effusion patients can provide important clinical information that will advance the field and allow better stratification of patients and planning of therapy accordingly. This review addresses the controversies in MPE diagnosis and management and exposes the deficits in knowledge of MPE that should be the focus of future research.

Keywords

malignant effusion - pleural - pleurodesis - indwelling pleural catheter - talc - cancer

Full Text

References

References
1 Bethune N. Pleural poudrage. J Thorac Cardiovasc Surg 1935; 1935 (4) 251-261
2 Lee YCG, Baumann MH, Maskell NA , et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003; 124 (6) 2229-2238
3 Sahn S, Heffner J. Pleural fluid analysis. In: Light RW, Lee YCG, , eds. Textbook of Pleural Diseases, 2nd ed. CRC Press; 2008: 209-226
4 Kradin RL, Fidias P, Digumarthy S, Mark EJ. Case records of the Massachusetts General Hospital. Case 17-2014. A 64-year-old man with chest pain and a pleural effusion. N Engl J Med 2014; 370 (22) 2132-2140
5 Porcel JM, Light RW. Pleural effusions. Dis Mon 2013; 59 (2) 29-57
6 Antonangelo L, Vargas FS, Acencio MM , et al. Effect of temperature and storage time on cellular analysis of fresh pleural fluid samples. Cytopathology 2012; 23 (2) 103-107
7 Lim MH, Garrettc J, Mowlem L, Yap E. Diagnosing malignant pleural effusions: how do we compare?. N Z Med J 2013; 126 (1381) 42-48
8 Swiderek J, Morcos S, Donthireddy V , et al. Prospective study to determine the volume of pleural fluid required to diagnose malignancy. Chest 2010; 137 (1) 68-73
9 Sallach SM, Sallach JA, Vasquez E, Schultz L, Kvale P. Volume of pleural fluid required for diagnosis of pleural malignancy. Chest 2002; 122 (6) 1913-1917
10 Thomas SC, Davidson LR, McKean ME. An investigation of adequate volume for the diagnosis of malignancy in pleural fluids. Cytopathology 2011; 22 (3) 179-183
11 Abouzgheib W, Bartter T, Dagher H, Pratter M, Klump W. A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. Chest 2009; 135 (4) 999-1001
12 Hooper C, Lee YC, Maskell N ; BTS Pleural Guideline Group. Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii4-ii17
13 Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 2014; 50 (5) 161-165
14 Bhanvadia MV, Santwani PM, Vachhani JH. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: study of 150 cases. Ethiop J Health Sci 2014; 24 (2) 125-131
15 Metzgeroth G, Kuhn C, Schultheis B, Hehlmann R, Hastka J. Diagnostic accuracy of cytology and immunocytology in carcinomatous effusions. Cytopathology 2008; 19 (4) 205-211
16 Porcel JM. Pleural fluid biomarkers: beyond the Light criteria. Clin Chest Med 2013; 34 (1) 27-37
17 Segal A, Sterrett GF, Frost FA , et al. A diagnosis of malignant pleural mesothelioma can be made by effusion cytology: results of a 20. year audit. Pathology 2013; 45 (1) 44-48
18 Koegelenberg CF, Diacon AH. Image-guided pleural biopsy. Curr Opin Pulm Med 2013; 19 (4) 368-373
19 Koegelenberg CF, Diacon AH. Pleural controversy: close needle pleural biopsy or thoracoscopy-which first?. Respirology 2011; 16 (5) 738-746
20 Froudarakis ME. New challenges in medical thoracoscopy. Respiration 2011; 82 (2) 197-200
21 Loddenkemper R. Thoracoscopy—state of the art. Eur Respir J 1998; 11 (1) 213-221
22 Yap KH, Phillips MJ, Lee YC. Medical thoracoscopy: rigid thoracoscopy or flexi-rigid pleuroscopy?. Curr Opin Pulm Med 2014; 20 (4) 358-365
23 Qureshi NR, Rahman NM, Gleeson FV. Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 2009; 64 (2) 139-143
24 Bugalho A, Ferreira D, Dias SS , et al. The diagnostic value of transthoracic ultrasonographic features in predicting malignancy in undiagnosed pleural effusions: a prospective observational study. Respiration 2014; 87 (4) 270-278
25 Botana-Rial M, Leiro-Fernández V, Represas-Represas C, González-Piñeiro A, Tilve-Gómez A, Fernández-Villar A. Thoracic ultrasound-assisted selection for pleural biopsy with Abrams needle. Respir Care 2013; 58 (11) 1949-1954
26 Canto A, Rivas J, Saumench J, Morera R, Moya J. Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983; 84 (2) 176-179
27 Koegelenberg C, Groote-Bidlingmaier FV, Bruwer JW , et al. An image-guided diagnostic pathway for undiagnosed pleural exudates. Eur Respir J 2013; 42 (Suppl. 57) 652s
28 Koegelenberg CF, Bolliger CT, Theron J , et al. Direct comparison of the diagnostic yield of ultrasound-assisted Abrams and Tru-Cut needle biopsies for pleural tuberculosis. Thorax 2010; 65 (10) 857-862
29 Diacon AH, Schuurmans MM, Theron J, Schubert PT, Wright CA, Bolliger CT. Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists. Respiration 2004; 71 (5) 519-522
30 Stigt JA, Boers JE, Groen HJ. Analysis of “dry” mesothelioma with ultrasound guided biopsies. Lung Cancer 2012; 78 (3) 229-233
31 Chang DB, Yang PC, Luh KT, Kuo SH, Yu CJ. Ultrasound-guided pleural biopsy with Tru-Cut needle. Chest 1991; 100 (5) 1328-1333
32 Leung AN, Müller NL, Miller RR. CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 1990; 154 (3) 487-492
33 Maskell NA, Gleeson FV, Davies RJ. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 2003; 361 (9366) 1326-1330
34 Adams RF, Gray W, Davies RJ, Gleeson FV. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest 2001; 120 (6) 1798-1802
35 Metintas M, Ak G, Dundar E , et al. Medical thoracoscopy vs CT scan-guided Abrams pleural needle biopsy for diagnosis of patients with pleural effusions: a randomized, controlled trial. Chest 2010; 137 (6) 1362-1368
36 Davies HE, Lee YC. Management of malignant pleural effusions: questions that need answers. Curr Opin Pulm Med 2013; 19 (4) 374-379
37 Wrightson JM, Fysh E, Maskell NA, Lee YCG. Risk reduction in pleural procedures: sonography, simulation and supervision. Curr Opin Pulm Med 2010; 16 (4) 340-350
38 Fysh ETH, Waterer GW, Kendall PA , et al. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion. Chest 2012; 142 (2) 394-400
39 Davies HE, Mishra EK, Kahan BC , et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012; 307 (22) 2383-2389
40 Reddy C, Ernst A, Lamb C, Feller-Kopman D. Rapid pleurodesis for malignant pleural effusions: a pilot study. Chest 2011; 139 (6) 1419-1423
41 Feller-Kopman D. Combining Talc Pleurodesis and IPC for Malignant Pleural Effusions. International Pleural Newsletter. 2013; 11 (1) 13-14
42 Chernow B, Sahn SA. Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med 1977; 63 (5) 695-702
43 Fysh E, Boshuizen R, Bielsa S , et al. An international study of predictors of the need for definitive therapy in patients with malignant pleural effusion. Intern Med J 2013; 43: 28-29
44 Fysh ET, Tan SK, Read CA , et al. Pleurodesis outcome in malignant pleural mesothelioma. Thorax 2013; 68 (6) 594-596
45 Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000; 117 (1) 73-78
46 Clive AO, Kahan BC, Hooper CE , et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax 2014; ; doi:10.1136/thoraxjnl-2014-205285
47 Roberts ME, Neville E, Berrisford RG, Antunes G, Ali NJ ; BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65 (Suppl. 02) ii32-ii40
48 Tan C, Sedrakyan A, Browne J, Swift S, Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006; 29 (5) 829-838
49 Shaw P, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev 2004; (1) CD002916
50 Boshuizen R, Thomas R, Lee Y. Use of indwelling pleural catheter for management of malignant pleural effusions: the advantages. Curr Respir Care Rep. 2013; 2: 93-99
51 Dresler CM, Olak J, Herndon II JE , et al; Cooperative Groups Cancer and Leukemia Group B; Eastern Cooperative Oncology Group; North Central Cooperative Oncology Group; Radiation Therapy Oncology Group. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127 (3) 909-915
52 Putnam Jr JB, Walsh GL, Swisher SG , et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000; 69 (2) 369-375
53 Putnam Jr JB, Light RW, Rodriguez RM , et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86 (10) 1992-1999
54 Hunt BM, Farivar AS, Vallières E , et al. Thoracoscopic talc versus tunneled pleural catheters for palliation of malignant pleural effusions. Ann Thorac Surg 2012; 94 (4) 1053-1057 , discussion 1057–1059
55 Davies HE, Lee YC, Davies RJO. Pleurodesis for malignant pleural effusion: talc, toxicity and where next?. [Editorial] Thorax 2008; 63 (7) 572-574
56 Campos JR, Werebe EC, Vargas FS, Jatene FB, Light RW. Respiratory failure due to insufflated talc. Lancet 1997; 349 (9047) 251-252
57 Janssen JP, Collier G, Astoul P , et al. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007; 369 (9572) 1535-1539
58 Van Meter ME, McKee KY, Kohlwes RJ. Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review. J Gen Intern Med 2011; 26 (1) 70-76
59 Fysh ETH, Tremblay A, Feller-Kopman D , et al. Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study. Chest 2013; 144 (5) 1597-1602
60 Mahmood K, Bower C. Treatment of infection associated with tunneled pleural catheters. J Bronchology Interv Pulmonol 2010; 17 (1) 69-72
61 Mekhaiel E, Kashyap R, Mullon JJ, Maldonado F. Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy. J Bronchology Interv Pulmonol 2013; 20 (4) 299-303
62 Morel A, Mishra E, Medley L , et al. Chemotherapy should not be withheld from patients with an indwelling pleural catheter for malignant pleural effusion. Thorax 2011; 66 (5) 448-449
63 Thomas R, Budgeon CA, Kuok YJ , et al. Catheter tract metastasis associated with indwelling pleural catheters. Chest 2014; 146 (3) 557-562
64 Davies HE, Musk AW, Lee YCG. Prophylactic radiotherapy for pleural puncture sites in mesothelioma: the controversy continues. Curr Opin Pulm Med 2008; 14 (4) 326-330
65 Janes SM, Rahman NM, Davies RJO, Lee YCG. Catheter-tract metastases associated with chronic indwelling pleural catheters. Chest 2007; 131 (4) 1232-1234
66 Fysh ET, Smith NA, Lee YC. Optimal chest drain size: the rise of the small-bore pleural catheter. Semin Respir Crit Care Med 2010; 31 (6) 760-768
67 Boshuizen RC, Onderwater S, Burgers SJA, van den Heuvel MM. The use of indwelling pleural catheters for the management of malignant pleural effusion—direct costs in a Dutch hospital. Respiration 2013; 86 (3) 224-228
68 Puri V, Pyrdeck TL, Crabtree TD , et al. Treatment of malignant pleural effusion: a cost-effectiveness analysis. Ann Thorac Surg 2012; 94 (2) 374-379 , discussion 379–380
69 Olden AM, Holloway R. Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis. J Palliat Med 2010; 13 (1) 59-65
70 Bhatnagar R, Maskell N. Indwelling pleural catheters for ambulatory out-patient care: a price worth paying?. Respiration 2013; 86 (3) 181-182
71 Tremblay A, Dumitriu S, Stather DR, Maceachern P, Illanes O, Kelly MM. Use of a drug eluting pleural catheter for pleurodesis. Exp Lung Res 2012; 38 (9-10) 475-482
72 Yim AP, Chan AT, Lee TW, Wan IY, Ho JK. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62 (6) 1655-1658
73 Terra RM, Junqueira JJ, Teixeira LR, Vargas FS, Pêgo-Fernandes PM, Jatene FB. Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis?. Chest 2009; 136 (2) 361-368
74 Harris RJ, Kavuru MS, Mehta AC , et al. The impact of thoracoscopy on the management of pleural disease. Chest 1995; 107 (3) 845-852
75 Furrer M, Rechsteiner R, Eigenmann V, Signer C, Althaus U, Ris HB. Thoracotomy and thoracoscopy: postoperative pulmonary function, pain and chest wall complaints. Eur J Cardiothorac Surg 1997; 12 (1) 82-87
76 Parulekar W, Di Primio G, Matzinger F, Dennie C, Bociek G. Use of small-bore vs large-bore chest tubes for treatment of malignant pleural effusions. Chest 2001; 120 (1) 19-25
77 Clementsen P, Evald T, Grode G, Hansen M, Krag Jacobsen G, Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter. A prospective randomized study. Respir Med 1998; 92 (3) 593-596
78 Mager HJ, Maesen B, Verzijlbergen F, Schramel F. Distribution of talc suspension during treatment of malignant pleural effusion with talc pleurodesis. Lung Cancer 2002; 36 (1) 77-81
79 Lorch DG, Gordon L, Wooten S, Cooper JF, Strange C, Sahn SA. Effect of patient positioning on distribution of tetracycline in the pleural space during pleurodesis. Chest 1988; 93 (3) 527-529
80 Dryzer SR, Allen ML, Strange C, Sahn SA. A comparison of rotation and nonrotation in tetracycline pleurodesis. Chest 1993; 104 (6) 1763-1766
81 Goodman A, Davies CW. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial. Lung Cancer 2006; 54 (1) 51-55
82 Villanueva AG, Gray Jr AW, Shahian DM, Williamson WA, Beamis Jr JF. Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions. Thorax 1994; 49 (1) 23-25
83 Thomas R, Francis R, Davies HE, Lee YC. Interventional therapies for malignant pleural effusions: the present and the future. Respirology 2014; 19 (6) 809-822